United States · FDA National Drug Code directory
Cetirizine Hydrochloride (Allergy)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68001-436_4262085e-1de6-302e-e063-6394a90a0026
- Product NDC
- 68001-436
- Form
- TABLET
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- BluePoint Laboratories
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200619
- Source listing expiry
- 20261231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (68001-436-04) / 30 TABLET in 1 BOTTLE · 68001-436-04
- 10 BLISTER PACK in 1 CARTON (68001-436-96) / 10 TABLET in 1 BLISTER PACK (68001-436-16) · 68001-436-96
- 1 BOTTLE in 1 CARTON (68001-436-97) / 300 TABLET in 1 BOTTLE · 68001-436-97
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →